Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma

scientific article published on 26 March 2008

Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3324/HAEMATOL.12057
P698PubMed publication ID18367485

P50authorAndreas RosenwaldQ28379725
Lorenz TrümperQ40931557
Wolfram KlapperQ88354630
Michael HummelQ89436457
Hilmar BergerQ90288040
Sergio B CogliattiQ114528525
Stefan BentinkQ116996863
Dido LenzeQ117262103
Carsten SchwaenenQ117262108
Swen WessendorfQ117262109
Judith DierlammQ117262125
Eugenia HaralambievaQ117262126
P2093author name stringReiner Siebert
Peter Möller
Rainer Spang
Harald Stein
German Ott
Markus Löffler
Eva M Murga Penas
Deutsche Krebshilfe Network Project "Molecular Mechanisms in Malignant Lymphomas"
P433issue5
P921main subjectdiffuse large B-cell lymphomaQ2626074
B-cell lymphomaQ4833719
P304page(s)688-696
P577publication date2008-03-26
P1433published inHaematologicaQ5638209
P1476titleGain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma
P478volume93

Reverse relations

cites work (P2860)
Q58761499Age-Related Chromosomal Aberrations in Patients with Diffuse Large B-Cell Lymphoma: An Approach
Q45973697Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas.
Q36965870B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice
Q34339662BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma
Q33836308CDCOCA: a statistical method to define complexity dependence of co-occuring chromosomal aberrations
Q37132882Cross-platform assessment of genomic imbalance confirms the clinical relevance of genomic complexity and reveals loci with potential pathogenic roles in diffuse large B-cell lymphoma
Q54471878Diffuse blastoid B-cell lymphoma: a histologically aggressive variant of t(14;18)-negative follicular lymphoma.
Q39381251Drug discovery and therapeutic delivery for the treatment of B and T cell tumors.
Q89184502Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2
Q41228856MALT1 promotes melanoma progression through JNK/c-Jun signaling
Q37699271MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo
Q60345350Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status
Q57909099Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Q33551720Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile
Q39198154Prospects for combining targeted and conventional cancer therapy with immunotherapy
Q90340960Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth
Q42040698The potential of copy number gains and losses, detected by array-based comparative genomic hybridization, for computational differential diagnosis of B-cell lymphomas and genetic regions involved in lymphomagenesis

Search more.